乐心医疗(300562.SZ)：预计2025年净利润同比增长32%～38.52%

Core Viewpoint - The company, 乐心医疗 (Lixun Medical), expects a net profit attributable to shareholders of 81 million to 85 million yuan for 2025, representing a year-on-year growth of 32.00% to 38.52% [1] Financial Performance - The projected net profit after deducting non-recurring gains and losses is estimated to be between 75 million and 79 million yuan, indicating a growth of 33.98% to 41.13% compared to the previous year [1] - The impact of non-recurring gains and losses on the company's net profit is expected to be approximately 6.3 million yuan [1] Strategic Focus - The company continues to focus on strategic transformation, emphasizing digital chronic disease management [1] - There is a commitment to implementing the company's medium to long-term strategic planning and annual operational plans [1] Operational Efficiency - The company has been optimizing its existing business and product structure, aiming to increase the proportion of high-profit customers, which has led to a steady improvement in overall gross profit margin [1] - Internal operational management has been refined to promote cost reduction and efficiency enhancement, optimizing resource allocation and improving operational efficiency [1] - Key operational metrics, such as accounts receivable turnover and inventory turnover, have shown effective improvement during the reporting period, contributing to a significant enhancement in overall profitability [1]